Filing Details
- Accession Number:
- 0001140361-18-000921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-04 20:16:43
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2018-01-04 20:16:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247681 | Bryan V Lawlis | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-02 | 3,750 | $38.59 | 18,610 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-02 | 3,750 | $88.84 | 14,860 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2018-01-02 | 3,750 | $0.00 | 3,750 | $38.59 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,750 | 2008-11-22 | 2018-05-21 | No | 4 | M | Direct |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on May 9, 2017.
- Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 1,050 shares as previously reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017.
- All shares sold at the same price.
- Reflects the number of stock options outstanding after the transaction from this specific stock option grant.
Billionaire Hedge Funds
